Streetbeat News

Products Services

ZYME

Zymeworks has made significant progress with its drug Ziihera, approved for second-line biliary tract cancer, and is set to start generating royalties. Phase 3 results for first-line GEA patients are expected in Q2 2025, marking a critical milestone for Zymeworks and its partner Jazz.

Portfolio Pulse from

December 19, 2024 | 2:15 pm

INTC

LNVGY

Lenovo and Intel have partnered with Grammy-winning artist Alessia Cara for the 'Made By' campaign, featuring a behind-the-scenes miniseries and exclusive live experience. This collaboration highlights Lenovo's technology and Intel's processors in the creative process of Cara's album trailer.

Portfolio Pulse from

December 19, 2024 | 2:15 pm

EGO

Val-d'Or Mining Corporation has provided an update on its exploration activities at the Perestroika and Perestroika Ouest prospects, which are under option to Eldorado Gold (Quebec) Inc. for the 2024 program.

Portfolio Pulse from

December 19, 2024 | 2:15 pm

ANSS

Ansys is collaborating with Sony Semiconductor Solutions to enhance scenario-based perception testing in autonomous vehicles. This partnership aims to improve the validation of ADAS/AV systems by using Ansys AVxcelerate Sensors and Sony's HDR Image Sensor Model, allowing for comprehensive testing in various weather and lighting conditions.

Portfolio Pulse from

December 19, 2024 | 2:15 pm

EZFL

SHEL

EzFill Holdings, Inc. has finalized a letter of understanding to purchase 78 trucks from Shell. These trucks will be used to service a large retailer and other customers in Texas and Arizona.

Portfolio Pulse from

December 19, 2024 | 2:00 pm

DVA

DaVita's stock has surged by 40.1% year-to-date, driven by strong performance in kidney care services and expansion into international markets.

Portfolio Pulse from

December 19, 2024 | 2:00 pm

QS

QuantumScape is discussed in the context of electric vehicles, which face challenges like long charging times and limited range. The article explores whether to buy, sell, or hold QuantumScape stock.

Portfolio Pulse from

December 19, 2024 | 2:00 pm

VKTX

Viking Therapeutics (VKTX) stock dropped 18% due to investor concerns about Merck's entry into the obesity market, which could increase competition for Viking's products.

Portfolio Pulse from

December 19, 2024 | 2:00 pm

CAG

Conagra, known for brands like Birds Eye and Healthy Choice, has increased its inflation outlook, expecting inflation to be close to 4%. This indicates a trend of sustained higher prices.

Portfolio Pulse from

December 19, 2024 | 2:00 pm

FTNT

Fortinet, a leading cybersecurity firm, shows strong growth and fundamentals but is currently overvalued. Investors are advised to wait for a better entry point due to high valuation risks and competitive market challenges.

Portfolio Pulse from

December 19, 2024 | 2:00 pm